NO306617B1 - Oksazolkinolinonderivater og medikament og farmasöytisk preparat derav - Google Patents

Oksazolkinolinonderivater og medikament og farmasöytisk preparat derav

Info

Publication number
NO306617B1
NO306617B1 NO953458A NO953458A NO306617B1 NO 306617 B1 NO306617 B1 NO 306617B1 NO 953458 A NO953458 A NO 953458A NO 953458 A NO953458 A NO 953458A NO 306617 B1 NO306617 B1 NO 306617B1
Authority
NO
Norway
Prior art keywords
oxazolquinolinone
drug
derivatives
pharmaceutical preparations
ch2ome
Prior art date
Application number
NO953458A
Other languages
English (en)
Norwegian (no)
Other versions
NO953458L (no
NO953458D0 (no
Inventor
Samir Jegham
Jean-Jacques Koenig
Frederic Puech
Philippe Burnier
Lydia Zard
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of NO953458D0 publication Critical patent/NO953458D0/no
Publication of NO953458L publication Critical patent/NO953458L/no
Publication of NO306617B1 publication Critical patent/NO306617B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Quinoline Compounds (AREA)
NO953458A 1994-09-05 1995-09-04 Oksazolkinolinonderivater og medikament og farmasöytisk preparat derav NO306617B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9410600A FR2724171B1 (fr) 1994-09-05 1994-09-05 Derives de 3,3a,4,5-tetrahydro-1h-oxazolo(3,4-a)quinolein-1-one, leur preparation et leur application en therapeutique

Publications (3)

Publication Number Publication Date
NO953458D0 NO953458D0 (no) 1995-09-04
NO953458L NO953458L (no) 1996-03-06
NO306617B1 true NO306617B1 (no) 1999-11-29

Family

ID=9466686

Family Applications (1)

Application Number Title Priority Date Filing Date
NO953458A NO306617B1 (no) 1994-09-05 1995-09-04 Oksazolkinolinonderivater og medikament og farmasöytisk preparat derav

Country Status (28)

Country Link
US (1) US5641785A (cs)
EP (1) EP0699680B1 (cs)
JP (1) JP4225585B2 (cs)
KR (1) KR100392523B1 (cs)
CN (1) CN1055472C (cs)
AT (1) ATE190311T1 (cs)
AU (1) AU687591B2 (cs)
CA (1) CA2157427C (cs)
CZ (1) CZ286128B6 (cs)
DE (1) DE69515402T2 (cs)
DK (1) DK0699680T3 (cs)
ES (1) ES2145886T3 (cs)
FI (1) FI110945B (cs)
FR (1) FR2724171B1 (cs)
GR (1) GR3033554T3 (cs)
HK (1) HK1013652A1 (cs)
HU (1) HU218587B (cs)
IL (1) IL115276A (cs)
NO (1) NO306617B1 (cs)
NZ (1) NZ272920A (cs)
PL (1) PL184412B1 (cs)
PT (1) PT699680E (cs)
RU (1) RU2141482C1 (cs)
SI (1) SI0699680T1 (cs)
SK (1) SK281867B6 (cs)
TW (1) TW356467B (cs)
UA (1) UA41916C2 (cs)
ZA (1) ZA957414B (cs)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1078632A1 (en) * 1999-08-16 2001-02-28 Sanofi-Synthelabo Use of monoamine oxydase inhibitors for the manufacture of drugs intended for the treatment of obesity
WO2005090309A1 (en) * 2004-03-12 2005-09-29 Wyeth 1,2-dihydroquinoline derivatives and method for using the same to treat hiv infection
NZ579431A (en) * 2007-03-09 2012-04-27 Sanofi Aventis Substituted dihydro and tetrahydro oxazolopyrimidinones, preparation and use thereof
RU2366430C2 (ru) 2007-05-23 2009-09-10 Виктор Иванович Рощин Ингибиторы моноаминооксидазы, лекарственное средство и фармацевтическая композиция
AR078171A1 (es) 2009-09-15 2011-10-19 Sanofi Aventis Dihidrobenzocicloalquiloximetil-oxazolopirimidinonas sustituidas, preparacion y uso de las mismas
CN105949120B (zh) * 2016-05-27 2018-07-24 广东工业大学 一种四齿螯合型单喹啉衍生物及其制备方法和作为神经退行性疾病的金属离子调节剂的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2624861B1 (fr) * 1987-12-21 1990-06-01 Delalande Sa Carbamates tricycliques, leur procede de preparation et leur application en therapeutique
ES2013391A6 (es) * 1989-02-08 1990-05-01 Consejo Superior Investigacion Procedimiento para la preparacion de derivados acetilenicos y alenicos de 2-aminometil -5-metoxiindoles.
JPH04295470A (ja) * 1991-03-22 1992-10-20 Wakamoto Pharmaceut Co Ltd モノアミンオキシダーゼ−ｂ酵素阻害活性を有する１，２，４−オキサジアゾール誘導体及びその製造法

Also Published As

Publication number Publication date
ZA957414B (en) 1996-04-15
NO953458L (no) 1996-03-06
SK108995A3 (en) 1996-06-05
ATE190311T1 (de) 2000-03-15
HK1013652A1 (en) 1999-09-03
HU9502578D0 (en) 1995-11-28
KR960010648A (ko) 1996-04-20
HUT73435A (en) 1996-07-29
IL115276A0 (en) 1996-01-19
CA2157427C (en) 2010-06-01
DE69515402T2 (de) 2000-10-19
US5641785A (en) 1997-06-24
SI0699680T1 (en) 2000-10-31
ES2145886T3 (es) 2000-07-16
KR100392523B1 (ko) 2003-11-12
CN1128763A (zh) 1996-08-14
EP0699680B1 (fr) 2000-03-08
CZ226295A3 (en) 1996-03-13
CZ286128B6 (cs) 2000-01-12
CN1055472C (zh) 2000-08-16
FI954141A (fi) 1996-03-06
FR2724171A1 (fr) 1996-03-08
GR3033554T3 (en) 2000-09-29
AU3041595A (en) 1996-03-21
PT699680E (pt) 2000-08-31
HU218587B (hu) 2000-10-28
JP4225585B2 (ja) 2009-02-18
PL310273A1 (en) 1996-03-18
NO953458D0 (no) 1995-09-04
TW356467B (en) 1999-04-21
FR2724171B1 (fr) 1997-01-03
DK0699680T3 (da) 2000-08-21
FI110945B (fi) 2003-04-30
IL115276A (en) 1998-12-06
CA2157427A1 (en) 1996-03-06
SK281867B6 (sk) 2001-08-06
EP0699680A1 (fr) 1996-03-06
RU2141482C1 (ru) 1999-11-20
JPH0899881A (ja) 1996-04-16
NZ272920A (en) 1998-03-25
AU687591B2 (en) 1998-02-26
PL184412B1 (pl) 2002-10-31
UA41916C2 (uk) 2001-10-15
FI954141A0 (fi) 1995-09-04
DE69515402D1 (de) 2000-04-13

Similar Documents

Publication Publication Date Title
SE8107537L (sv) Nya derivat av heterocykliska aminoalcoyler, deras framstellningssett och deras terapeutiska anvendning
FI945703A (fi) 3,4,4-trisybstituoitujen piperidinyyli-N-alkyylikarboksylaattien ja välituotteiden valmistus
CY1107391T1 (el) Αρυλσυμπυκνωμενες αζαπολυκυκλικες ενωσεις
FI943749A (fi) Taksaanijohdannaisten fosfono-oksimetyylieetterit
SE8902326D0 (sv) Karboxamidfoereningar, foerfaranden foer framstaellning av dem och farmceutiska kompositioner som innehaaller dem
DE69302508D1 (de) Taxanderivate, ihre Herstellung und ihre Anwendung in der Onkologie
DE3879787D1 (de) 11beta-phenyl-4,9,15-estratriene, deren herstellung und diese enthaltende pharmazeutische praeparate.
KR920002151A (ko) 15-케토-프로스타글란딘 화합물에 의한 염증성 질환 치료
NO306617B1 (no) Oksazolkinolinonderivater og medikament og farmasöytisk preparat derav
GR920100570A (el) Παραγωγα 3(2η)-πυριδαζινονης και μεθοδος για την παρασκευη τους.
ATE159251T1 (de) Tropolonderivate und pharmazeutische zubereitungen davon zur vorbeugung und behandlung von ischämischen krankheiten
FR2716198B1 (fr) Facteur cytotoxique tel qu'associé à la sclérose en plaques, sa détection et sa quantification.
FI912269A0 (fi) 3'-deamino - 4'deoxi - 4'-amino- 8 -fluorantracykliner och framstaellningsfoerfaranden foer dessa.
ATE176477T1 (de) Neue phospholipidderivate
ES2143159T3 (es) Nuevos derivados de 2-ciano-3-hidroxi-propenamidas que comprenden un radical trifluorometilsulfonilfenilo/trifluorometilsulfinilfenilo, procedimiento de preparacion, aplicacion como medicamentos y composiciones farmaceuticas que los contienen.
DE59003446D1 (de) 13-Brom und 13, 14-Dibrom-Ergoline, ihre Herstellung und Verwendung in Arzneimitteln.
SE9203824L (sv) Bensofuranylimidazol-derivat, foerfarande foer framstaellning daerav och terapeutiska kompositioner innehaallande desamma
DE3865521D1 (de) 4-methyl-4-phenyl-1-pentanale, deren herstellung und verwendung als riechstoffe.
DE69434010D1 (de) C7-Taxan-Derivate und diese enthaltende pharmazeutische Zusammenstellungen
DK0779075T3 (da) Anvendelse af 3-alpha-hydroxy-5-alpha-androsta-16-en som lægemidler
FI902272A0 (fi) Foerfarande foer isolering och vidarerening av plasmaproteinerna ttr och rbp.
FI914372A0 (fi) Foerfarande foer isolering och vidarerening av plasmaproteiners ttr och rbp.

Legal Events

Date Code Title Description
MK1K Patent expired